Santhera’s cystic fibrosis drug POL6014 in line for orphan status
admin 15th October 2018 Uncategorised 0Santhera says its experimental cystic fibrosis drug POL6014 is likely to be designated an orphan drug in the next 30 days, putting the firm in line to receive regulatory and financial incentives for its further development.
More: Santhera’s cystic fibrosis drug POL6014 in line for orphan status
Source: News